CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 49.50
+1.22 (2.53%)
Sep 30, 2025, 4:08 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 16.51 billion as of September 30, 2025. Its market cap has increased by 124.74% in one year.
Market Cap
16.51B
Enterprise Value
14.99B
Revenue
1.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
49.50
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 16.51B, an increase of 118.04%. That is a compound annual growth rate of 12.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 16.51B | 42.18% |
| Dec 31, 2024 | 11.61B | -7.06% |
| Dec 29, 2023 | 12.49B | -54.89% |
| Dec 30, 2022 | 27.69B | -58.12% |
| Dec 31, 2021 | 66.11B | -11.16% |
| Dec 31, 2020 | 74.41B | 466.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 285.15B |
| Hansoh Pharmaceutical Group Company | 214.55B |
| JD Health International | 212.90B |
| WuXi Biologics | 166.53B |
| Innovent Biologics | 160.31B |
| Sino Biopharmaceutical | 145.52B |
| Akeso | 130.07B |
| Sichuan Kelun-Biotech Biopharmaceutical | 115.57B |